Primus Pharmaceuticals, Inc.: New Patent Issued for Limbrel(R)

Published: May 26, 2009

SCOTTSDALE, Ariz.--(BUSINESS WIRE)--Primus Pharmaceuticals, Inc. announces the issuance of a new composition of matter patent for Limbrel, the first prescription medical food product to safely meet the distinctive nutritional requirements of patients with osteoarthritis (OA). U.S. Patent #7,514,469 was recently issued by the U.S. Patent and Trademark Office.

Back to news